NeueHealth Q1 net income $5.7M vs loss of $53.9M YoY; adj. EBITDA $2.5M; revenue $245M

NeueHealth, Inc.

2024-Q1 EPS reported -$3.53 revenue$245,095,000

Revenue of $245.1M, down 18% YoY from $300.6M; net income from continuing ops of $5.7M vs loss of $53.9M.
Adjusted EBITDA of $2.5M in Q1’24 vs negative $5.7M YoY; 2024 adj. EBITDA guidance maintained at $15-25M.
Value-Based Consumers served 360,000 (down 3.5% YoY); Enablement Services Lives surged to 109,000 from 27,000.
2014 full-year revenue guidance ~$1B with NeueCare segment $310-320M and NeueSolutions $690-700M.
Adjusted Operating Cost Ratio guided at 15-16% (ex-corporate) and 19-20% (inclusive) for 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NeueHealth, Inc. reported first quarter ended March 31, 2024 results: revenue $245,095, net income $5,688. Guidance reaffirmed.

Period: first quarter ended March 31, 2024
Revenue: $245,095
Net income: $5,688
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Metrics Value-Based Consumers served 360,000 373,000 Enablement Services Lives 109,000 27,000 Three Months Ended ($ in thousands) March 31, 2024 2023 Financial Metrics Revenue $ 245,095 $ 300,550 Net Income (Loss) from Continuing Operations $ 5,688 $ (53,918) Adjusted EBITDA (non-GAAP) $ 2,529 $ (5,743) See the table at the end of this release for additional

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001671284-24-000032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.